XML 33 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Adoption of ASU No. 2016-13 (Note 2)
As of January 1, 2023
Previous Partnerships' Capital Existing Until the Recapitalization of Granite Ridge Resources, Inc.
Previous Partnerships' Capital Existing Until the Recapitalization of Granite Ridge Resources, Inc.
As of January 1, 2023
Common Stock Issued
Common Stock Issued
As of January 1, 2023
Additional Paid-in Capital
Additional Paid-in Capital
As of January 1, 2023
Retained Earnings
Retained Earnings
Adoption of ASU No. 2016-13 (Note 2)
Retained Earnings
As of January 1, 2023
Treasury Stock
Treasury Stock
As of January 1, 2023
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Contributed capital $ 47,000     $ 47,000                    
Balance at beginning of period at Dec. 31, 2020 370,556     370,556   $ 0   $ 0   $ 0     $ 0  
Balance at beginning of period (in shares) at Dec. 31, 2020           0                
Begging balance, treasury stock (in shares) at Dec. 31, 2020                         0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Cash distributions (51,085)     (51,085)                    
Net income 108,459     108,459                    
Balance at ending of period at Dec. 31, 2021 474,930     474,930   $ 0   0   0     $ 0  
Balance at ending of period (in shares) at Dec. 31, 2021           0                
Ending balance, treasury stock (in shares) at Dec. 31, 2021                         0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net income prior to Business Combination 219,292     219,292                    
Contribution of Funds' assets in exchange for common stock (in shares)           130,000,000                
Contribution of Funds' assets in exchange for common stock       (694,222)   $ 13   694,209            
Recapitalization (in shares)           2,923,000                
Recapitalization 6,825             6,825            
Issuance costs (18,508)             (18,508)            
Issuance of common stock warrants (12,265)             (12,265)            
Issuance of vesting shares (in shares)           372,000                
Issuance of vesting shares (1,287)             (1,287)            
Deferred income tax liability at Business Combination (36,899)             (36,899)            
Purchase of treasury stock (in shares)                         (26,000)  
Purchase of treasury stock (229)                       $ (229)  
Common stock dividend declared (10,664)                 (10,664)        
Net income subsequent to the Business Combination 43,052                 43,052        
Net income 262,344                          
Balance at ending of period at Dec. 31, 2022 $ 664,247 $ (118) $ 664,129 0 $ 0 $ 13 $ 13 632,075 $ 632,075 32,388 $ (118) $ 32,270 $ (229) $ (229)
Balance at ending of period (in shares) at Dec. 31, 2022 133,294,897         133,295,000 133,295,000              
Ending balance, treasury stock (in shares) at Dec. 31, 2022 (25,920)                       (26,000) (26,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Accounting Standards Update [Extensible Enumeration]   Accounting Standards Update 2016-13 [Member]                        
Purchase of treasury stock (in shares)                         (5,652,000)  
Purchase of treasury stock $ (36,096)                       $ (36,096)  
Common stock dividend declared (58,587)                 (58,587)        
Grants of restricted stock (in shares)           403,000                
Forfeitures of restricted stock (in shares)           (13,000)                
Cancellation of vesting shares (in shares)           (221,000)                
Vesting shares 1,287             1,287            
Stock-based compensation 2,162             2,162            
Common stock issued in warrant exchange (in shares)           2,576,000                
Common stock issued in warrant exchange 17,646         $ 1   17,645            
Common stock issued for exercise of warrants (in shares)           1,000                
Common stock issued for exercise of warrants 5             5            
Net income 81,099                 81,099        
Balance at ending of period at Dec. 31, 2023 $ 671,645     $ 0   $ 14   $ 653,174   $ 54,782     $ (36,325)  
Balance at ending of period (in shares) at Dec. 31, 2023 136,040,777         136,041,000                
Ending balance, treasury stock (in shares) at Dec. 31, 2023 (5,677,627)                       (5,678,000)